Intimation of the Voting Results and the Scrutinizer''s Report for the Annual General Meeting of the Company held on Thursday, July, 2025.
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India held its 77th AGM on July 31, 2025 via video conferencing, with all four ordinary resolutions passed with overwhelming shareholder approval (over 99.99% in favor). The resolutions covered adoption of audited financial statements for FY ended March 31, 2025, declaration of a final dividend, reappointment of Mr. Falin Majmudar as Director (retiring by rotation), and appointment of MK Saraf & Associates LLP as Secretarial Auditors. Of the 40,826 shareholders on record, only 44 attended via VC. Promoters voted with 100% of their 1,74,50,680 shares in favor, while public participation was very low — only about 18.48% of institutional and 0.27% of non-institutional public shares were polled. Total valid votes cast were around 1.75 crore shares across all resolutions.
The results confirm routine corporate housekeeping — final dividend for FY25 has been approved by shareholders, a director has been reappointed, and a new secretarial auditor is in place. With near-unanimous promoter support and negligible dissent, there is no governance surprise or material event for shareholders. No immediate stock-price catalyst is expected from this filing.